| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |